Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic... J Cancer Res Clin Oncol (2017) 143:1701–1712 DOI 10.1007/s00432-017-2428-0 ORIGINAL ARTICLE – CANCER RESEARCH Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post‑metastatic survival: 35‑year results from the Munich Cancer Registry 1 1 2 3 4 5 6 Dieter Hölzel · Renate Eckel · Ingo Bauerfeind · Bernd Baier · Thomas Beck · Michael Braun · Johannes Ettl · 5 6 7 8 3 9 Ulrich Hamann · Marion Kiechle · Sven Mahner · Christian Schindlbeck · Johann de Waal · Nadia Harbeck · Jutta Engel Received: 12 April 2017 / Accepted: 13 April 2017 / Published online: 20 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract of liver and CNS METs has more than doubled, the rate of Purpose Systemic therapies (ATHs) in early breast cancer lung METs remains stable, and the rate of bone METs has have improved the survival of breast cancer (BC) patients been reduced by approximately 50%. MFS has been pro- in recent decades. The magnitude of the changes in overall, longed with a hazard ratio 0.75 (P < 0.0001), but PMS has metastasis-free (MFS) and post-metastatic (PMS) survival declined (hazard ratio 1.36; P < 0.0001); however, http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Cancer Research and Clinical Oncology Springer Journals

Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post-metastatic survival: 35-year results from the Munich Cancer Registry

Loading next page...
 
/lp/springer_journal/improved-systemic-treatment-for-early-breast-cancer-improves-cure-F7utwlUXmD
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Medicine & Public Health; Oncology; Cancer Research; Internal Medicine; Hematology
ISSN
0171-5216
eISSN
1432-1335
D.O.I.
10.1007/s00432-017-2428-0
Publisher site
See Article on Publisher Site

Abstract

J Cancer Res Clin Oncol (2017) 143:1701–1712 DOI 10.1007/s00432-017-2428-0 ORIGINAL ARTICLE – CANCER RESEARCH Improved systemic treatment for early breast cancer improves cure rates, modifies metastatic pattern and shortens post‑metastatic survival: 35‑year results from the Munich Cancer Registry 1 1 2 3 4 5 6 Dieter Hölzel · Renate Eckel · Ingo Bauerfeind · Bernd Baier · Thomas Beck · Michael Braun · Johannes Ettl · 5 6 7 8 3 9 Ulrich Hamann · Marion Kiechle · Sven Mahner · Christian Schindlbeck · Johann de Waal · Nadia Harbeck · Jutta Engel Received: 12 April 2017 / Accepted: 13 April 2017 / Published online: 20 April 2017 © Springer-Verlag Berlin Heidelberg 2017 Abstract of liver and CNS METs has more than doubled, the rate of Purpose Systemic therapies (ATHs) in early breast cancer lung METs remains stable, and the rate of bone METs has have improved the survival of breast cancer (BC) patients been reduced by approximately 50%. MFS has been pro- in recent decades. The magnitude of the changes in overall, longed with a hazard ratio 0.75 (P < 0.0001), but PMS has metastasis-free (MFS) and post-metastatic (PMS) survival declined (hazard ratio 1.36; P < 0.0001); however,

Journal

Journal of Cancer Research and Clinical OncologySpringer Journals

Published: Apr 20, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off